BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34267523)

  • 1. Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.
    Tewabe A; Abate A; Tamrie M; Seyfu A; Abdela Siraj E
    J Multidiscip Healthc; 2021; 14():1711-1724. PubMed ID: 34267523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresponsive Polymers for Nanomedicine-Expectations and Reality!
    Quader S; Van Guyse JFR
    Polymers (Basel); 2022 Sep; 14(17):. PubMed ID: 36080733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ cellular hitchhiking of nanoparticles for drug delivery.
    Udofa E; Zhao Z
    Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting strategies for bone diseases: signaling pathways and clinical studies.
    Xu H; Wang W; Liu X; Huang W; Zhu C; Xu Y; Yang H; Bai J; Geng D
    Signal Transduct Target Ther; 2023 May; 8(1):202. PubMed ID: 37198232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?
    Lussier F; Staufer O; Platzman I; Spatz JP
    Trends Biotechnol; 2021 May; 39(5):445-459. PubMed ID: 32912650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paul Ehrlich's magic bullet concept: 100 years of progress.
    Strebhardt K; Ullrich A
    Nat Rev Cancer; 2008 Jun; 8(6):473-80. PubMed ID: 18469827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting active cancer cells with smart bullets.
    Martel S
    Ther Deliv; 2017 Mar; 8(5):301-312. PubMed ID: 28361606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeting with nano-sized carrier systems.
    Yokoyama M
    J Artif Organs; 2005; 8(2):77-84. PubMed ID: 16094510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination cancer immunotherapy "Expanding Paul Ehrlich's Magic Bullet Concept".
    Elliott RL
    Surg Oncol; 2012 Mar; 21(1):53-5. PubMed ID: 20338747
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted Drug Delivery Systems and Their Therapeutic Applications in Cancer and Immune Pathological Conditions.
    Iqbal J; Anwar F; Afridi S
    Infect Disord Drug Targets; 2017; 17(3):149-159. PubMed ID: 28595539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium phosphate-based nanosystems for advanced targeted nanomedicine.
    Degli Esposti L; Carella F; Adamiano A; Tampieri A; Iafisco M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1223-1238. PubMed ID: 29528248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
    Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
    Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [100 years of Dr. Ehrlich's magic bullet (1909-2009)].
    García-Sánchez JE; García E; Merino ML
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):521-33. PubMed ID: 20097455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11–14 September 2012 .
    Feijen J; Hennink WE; Zhong Z
    Nanomedicine (Lond); 2013 Feb; 8(2):177-80. PubMed ID: 23394154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origins and evolution of "controlled" drug delivery systems.
    Hoffman AS
    J Control Release; 2008 Dec; 132(3):153-63. PubMed ID: 18817820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.
    Raucher D; Dragojevic S; Ryu J
    Front Oncol; 2018; 8():624. PubMed ID: 30619758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.